CoinScoop21Shares advances plans for Injective ETF
21Shares is moving forward with its Injective ETF, which is slated for listing on the Nasdaq. The fund intends to stake up to 60 percent of its INJ holdings to generate additional yield. This initiative marks the firm's entry into a significantly smaller market compared to its previous crypto ETF offerings.
Summaries are written by AI from the original article. Not investment advice.